Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

欧唐宁 - NMPA Drug Approval Details

Approvals/NMPA/Linagliptin Tablets

Approved

化学药品

Linagliptin Tablets

WEST WARD COLUMBUS INC🇨🇳 National Medical Products Administration

Approval Date: Dec 18, 2017
Approval ID: 7MaoUn0ti8G
Company: WEST WARD COLUMBUS INC
Type: 化学药品

Approval Details

Approval Id: 7MaoUn0ti8G
Approval Number: 国药准字J20171087
Generic Name: 利格列汀片
Generic Name En: Linagliptin Tablets
Trade Name: 欧唐宁
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 7片/盒；10片/盒；14片/盒；28片/盒；30片/盒；60片/盒
Reg Date: 2017-12-18
Company Name: WEST WARD COLUMBUS INC
Company Address: Binger Strasse173，55216 Ingelheim am Rhein, Germany
Production Company Name: WEST WARD COLUMBUS INC
Production Company Address: 1809 Wilson Road, Columbus, Ohio 43228 USA
Company Detail Path: /organization/west-ward-columbus-inc
Production Company Detail Path: /organization/west-ward-columbus-inc

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 18, 2017

Approval ID

7MaoUn0ti8G

Type

化学药品

Back to NMPA Approvals